ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 186

Impact of TLR Stimulation on Cytokine Production in Macrophage Subsets: TLR2 Stimulation Impairs Anti-Inflammatory Activity of M2 Macrophages

Lilian Quero, Anke Gehringer and Diego Kyburz, Department of Biomedicine, Experimental Rheumatology, University of Basel, 4051 Basel, Switzerland

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Macrophage

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Innate Immunity and Rheumatic Disease - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Toll-like receptors (TLRs) have been shown to contribute to the inflammatory response in rheumatoid arthritis (RA). A number of TLRs have been found to be upregulated in synovial tissue (TLR2, TLR3, TLR4), synovial monocytes (TLR4) as well as macrophages (TLR2, TLR4) in RA versus osteoarthritis (OA). Based on phenotypic and functional differences macrophages can be divided into different subsets. At present there is limited knowledge on the functional role of macrophage subsets in rheumatoid arthritis. Here we investigated the impact of TLR2, TLR3 and TLR4 signaling on monocytes (M0) and monocyte derived M1 and M2 macrophages. We compared inflammatory and anti-inflammatory cytokine release, cell surface marker and TLR gene expression as well as viability of M0, M1 and M2 macrophages.

Methods: Monocytes were isolated from buffy coats of 4-6 healthy donors by CD14 microbead separation and differentiated into M1 and M2 by culturing them in the presence of 50ng/ml GM-CSF and M-CSF, respectively, for 6 to 8 days. For M0, CD14+ cells were kept in standard medium for 3 days. Subsequently, cells were stimulated for 24 hours with Pam3, LPS or PolyIC. Cytokine release was measured by ELISA, gene expression by qRT-PCR and viability by WST-1 assay. Cells were stained with fluorescently labeled antibodies for CD markers and analyzed by FACS.

Results: We demonstrate that stimulation of M2 macrophages with the TLR2-ligand Pam3 but not with the TLR4-ligand LPS leads to a decrease in the IL-10/IL-6 and IL-10/IL-8 ratio. TLR2 and TLR3 basal gene expression levels were similar between the cell types, whereas TLR4 expression was 3.7 fold higher in M2 than M0 or M1. TLR4 was strongly downregulated by LPS and Pam3 in M1 and M2, but not in M0. In contrast, TLR2 was upregulated by Pam3 and LPS. CD14 and CD163 expression was not affected by TLR ligands. CD86 levels were increased in M1 by all TLR ligands tested and in M0 by Pam3 but decreased in M2 by LPS and Pam3. CD80 was increased by Pam3 and LPS in M1 and by LPS in M2. Stimulation with TLR2 ligands was found to significantly increase M2 viability.

Conclusion: We demonstrate that stimulation of in vitro differentiated M2 macrophages with TLR2 ligands leads to increased proinflammatory cytokine production, suggesting that the antiinflammatory activity of M2 macrophages is reduced in an inflammatory milieu with abundant TLR2 ligands as can be found in RA. In line with these observations, Pam3 upregulated TLR2 mRNA expression in M2 macrophages in an autocrine fashion and increased M2 viability, thereby enhancing TLR2-induced proinflammatory effects.


Disclosure: L. Quero, None; A. Gehringer, None; D. Kyburz, None.

To cite this abstract in AMA style:

Quero L, Gehringer A, Kyburz D. Impact of TLR Stimulation on Cytokine Production in Macrophage Subsets: TLR2 Stimulation Impairs Anti-Inflammatory Activity of M2 Macrophages [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/impact-of-tlr-stimulation-on-cytokine-production-in-macrophage-subsets-tlr2-stimulation-impairs-anti-inflammatory-activity-of-m2-macrophages/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-tlr-stimulation-on-cytokine-production-in-macrophage-subsets-tlr2-stimulation-impairs-anti-inflammatory-activity-of-m2-macrophages/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology